Beranda › Kanker Paru Non-Sel Kecil › Montana › Bozeman
Uji klinis Kanker Paru Non-Sel Kecil di Bozeman, MT
10 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Bozeman (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Menerima pesertaFase 3
- Bozeman Health Deaconess Hospital, Bozeman
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Bozeman Health Deaconess Hospital, Bozeman
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Bozeman Health Deaconess Hospital, Bozeman
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- Bozeman Health Deaconess Hospital - Bozeman Health Cancer Center, Bozeman
- Bozeman Health Deaconess Hospital - Bozeman Health Clinical Research, Bozeman
- Bozeman Health Deaconess Hospital, Bozeman
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Menerima pesertaFase 2
- Bozeman Health Deaconess Hospital, Bozeman
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Bozeman Health Deaconess Hospital, Bozeman
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Bozeman Health Deaconess Hospital, Bozeman
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Bozeman Health Deaconess Hospital, Bozeman
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Bozeman Health Deaconess Hospital, Bozeman
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Bozeman Health Deaconess Hospital, Bozeman
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Bozeman
- Kanker Prostat10 studi
- Kanker Paru10 studi
- Leukemia Mieloid Akut6 studi
- Melanoma6 studi
- Kanker Kandung Kemih5 studi
- Kanker Payudara5 studi
- Kanker Kolon5 studi
- Kanker Ovarium4 studi
- Karsinoma Sel Skuamosa Kepala dan Leher4 studi
- Kanker Endometrium4 studi
- Kanker Rektum4 studi
- Kanker Kolorektal4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.